T. Rowe Price Associates’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.7M Sell
2,713,230
-17,052
-0.6% -$473K 0.01% 710
2025
Q4
$75.7M Buy
2,730,282
+467,133
+21% +$11.9M 0.01% 691
2025
Q3
$54.9M Sell
2,263,149
-179,727
-7% -$3.58M 0.01% 779
2025
Q2
$41.6M Sell
2,442,876
-583,825
-19% -$10.2M ﹤0.01% 773
2025
Q1
$59.1M Buy
3,026,701
+1,273,559
+73% +$33.4M 0.01% 673
2024
Q4
$43.5M Buy
1,753,142
+266,834
+18% +$6.81M 0.01% 798
2024
Q3
$36.4M Buy
1,486,308
+92,635
+7% +$2.39M ﹤0.01% 841
2024
Q2
$32.7M Buy
1,393,673
+147,484
+12% +$3.62M ﹤0.01% 838
2024
Q1
$41.2M Buy
1,246,189
+1,207,699
+3,138% +$37.6M 0.01% 775
2023
Q4
$1.05M Buy
38,490
+2,165
+6% +$53.8K ﹤0.01% 1852
2023
Q3
$874K Buy
36,325
+2,100
+6% +$56.3K ﹤0.01% 1858
2023
Q2
$1.09M Buy
34,225
+3,656
+12% +$119K ﹤0.01% 1759
2023
Q1
$937K Buy
30,569
+971
+3% +$38.3K ﹤0.01% 1822
2022
Q4
$1.16M Buy
29,598
+2,553
+9% +$114K ﹤0.01% 1694
2022
Q3
$1.29M Buy
27,045
+3,560
+15% +$203K ﹤0.01% 1630
2022
Q2
$909K Buy
23,485
+1,549
+7% +$61.6K ﹤0.01% 1945
2022
Q1
$1.26M Buy
21,936
+3,136
+17% +$206K ﹤0.01% 1890
2021
Q4
$1.5M Sell
18,800
-4,393
-19% -$376K ﹤0.01% 1824
2021
Q3
$2.02M Sell
23,193
-2,691
-10% -$270K ﹤0.01% 1722
2021
Q2
$3.33M Sell
25,884
-25,939
-50% -$2.07M ﹤0.01% 1591
2021
Q1
$4.15M Buy
51,823
+41,630
+408% +$3.96M ﹤0.01% 1508
2020
Q4
$832K Buy
+10,193
New +$501K ﹤0.01% 2015
2020
Q3
Sell
-444,449
Closed -$12.4M 2593
2020
Q2
$12.4M Sell
444,449
-11,998
-3% -$259K ﹤0.01% 1252
2020
Q1
$8.22M Buy
+456,447
New +$9.92M ﹤0.01% 1263

Other funds holding BEAM